Aurora Cannabis (TSE:ACB) Issues Quarterly Earnings Results

Aurora Cannabis (TSE:ACB) issued its quarterly earnings results on Thursday. The company reported C$0.05 earnings per share for the quarter, FiscalAI reports. The firm had revenue of C$86.02 million during the quarter. Aurora Cannabis had a negative net margin of 9.53% and a negative return on equity of 5.21%.

Aurora Cannabis Trading Up 1.5%

Shares of ACB traded up C$0.11 during mid-day trading on Friday, reaching C$7.40. 795,641 shares of the company were exchanged, compared to its average volume of 421,858. Aurora Cannabis has a 52 week low of C$3.59 and a 52 week high of C$8.75. The company has a debt-to-equity ratio of 4.30, a quick ratio of 2.48 and a current ratio of 5.36. The business has a 50 day simple moving average of C$5.83 and a two-hundred day simple moving average of C$4.96. The stock has a market capitalization of C$468.49 million, a PE ratio of -3.81 and a beta of 0.26.

Analyst Ratings Changes

A number of research firms recently issued reports on ACB. ATB Cormark Capital Markets lifted their price target on Aurora Cannabis from C$5.60 to C$7.00 and gave the company a “tender” rating in a report on Tuesday, October 6th. BMO Capital Markets upgraded Aurora Cannabis to a “hold” rating in a report on Wednesday, August 5th. TD lowered shares of Aurora Cannabis from a “buy” rating to a “sell” rating and reduced their target price for the stock from C$8.00 to C$7.80 in a research note on Wednesday. Finally, TD Securities downgraded Aurora Cannabis from a “strong-buy” rating to a “strong sell” rating in a research report on Tuesday. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Reduce” and a consensus target price of C$6.60.

Aurora Cannabis Company Profile

Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty’s ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿.